Holen Sie sich die Stockscreener-App
21.86
2.58%
0.55
Handel nachbörslich:
21.86
Schlusskurs vom Vortag:
$21.31
Offen:
$21.91
24-Stunden-Volumen:
1.15M
Relative Volume:
1.38
Marktkapitalisierung:
$1.01B
Einnahmen:
$595.19M
Nettoeinkommen (Verlust:
$28.96M
KGV:
-17.24
EPS:
-1.2679
Netto-Cashflow:
$30.93M
1W Leistung:
+1.34%
1M Leistung:
-21.59%
6M Leistung:
-23.97%
1J Leistung:
-41.16%
1-Tages-Spanne:
$21.17
$22.19
1-Wochen-Bereich:
$19.93
$22.19
52-Wochen-Spanne:
$19.93
$41.73
Azenta Inc Stock (AZTA) Company Profile
Firmenname
Azenta Inc
Sektor
Telefon
(978) 262-2400
Adresse
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
21.86 | 981.57M | 595.19M | 28.96M | 30.93M | -1.2679 |
ISRG
Intuitive Surgical Inc
|
469.98 | 167.61B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
158.27 | 44.35B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
75.26 | 36.19B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
42.67 | 34.11B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
226.31 | 33.24B | 5.40B | 1.49B | 1.78B | 10.12 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-12-19 | Bestätigt | Needham | Buy |
| 2025-10-30 | Hochstufung | Jefferies | Hold → Buy |
| 2025-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-07-22 | Fortgesetzt | Stephens | Equal-Weight |
| 2024-12-18 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2024-04-04 | Eingeleitet | Jefferies | Hold |
| 2024-02-01 | Bestätigt | B. Riley Securities | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-03-31 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-03-21 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Azenta Inc Aktie (AZTA) Neueste Nachrichten
Azenta: Life Science Player Fails To Come To Life (NASDAQ:AZTA) - Seeking Alpha
Congress Asset Management Co. Invests $42.76 Million in Azenta, Inc. $AZTA - MarketBeat
Contrasting Azenta (NASDAQ:AZTA) & Talkspace (NASDAQ:TALK) - Defense World
Trading Recap: Is Azenta Inc stock trending bullishForecast Cut & Free Reliable Trade Execution Plans - baoquankhu1.vn
Needham reiterates Azenta stock rating citing growth drivers By Investing.com - Investing.com Australia
Azenta's (AZTA) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
Needham reiterates Azenta stock rating citing growth drivers - Investing.com
Needham Reiterates Buy Rating on Azenta (AZTA) with Price Target of $44 | AZTA Stock News - GuruFocus
Azenta (NASDAQ:AZTA) Hits New 1-Year LowHere's What Happened - MarketBeat
Azenta Details UK Biocentre Buyout to Expand Europe Biobanking, Near-Term EBITDA Dilution Seen - Yahoo Finance
Azenta stock hits 52-week low at $22.44 By Investing.com - Investing.com India
Azenta stock hits 52-week low at $22.44 - Investing.com
Azenta, Inc. (AZTA) Uk Biocentre LimitedM&A CallSlideshow (NASDAQ:AZTA) 2026-03-10 - Seeking Alpha
Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast - GuruFocus
Aug Reactions: Can Azenta Inc sustain earnings growthMarket Volume Report & Smart Allocation Stock Tips - baoquankhu1.vn
Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know - Yahoo Finance
GW&K Investment Management LLC Has $32.47 Million Stake in Azenta, Inc. $AZTA - MarketBeat
Osborne Clarke advises shareholders of UK Biocentre on sale to Azenta Life Sciences - Osborne Clarke
Azenta Acquires UK Biocentre to Expand European Biorepository - The Globe and Mail
Azenta Details Turnaround at Raymond James Conference, Targets Margin Gains and Recurring Revenue Growth - MarketBeat
Investor Mood: Is Azenta Inc stock trending bullish2025 Support & Resistance & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Fisher Asset Management LLC Sells 48,408 Shares of Azenta, Inc. $AZTA - MarketBeat
AZTA Technical Analysis & ETF Price Forecast - Intellectia AI
Azenta acquires UK Biocentre for £20.5 million By Investing.com - Investing.com Canada
Azenta acquires UK Biocentre for £20.5 million - Investing.com South Africa
Azenta completes strategic acquisition of UK Biocentre Limited, to expand biorepository capabilities - marketscreener.com
Azenta to Acquire UK Biocentre for GBP 20.5 Million to Build European SRS Hub - TradingView
Azenta (AZTA) acquires UK Biocentre in GBP 20.5m European hub deal - Stock Titan
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities - marketscreener.com
Vanguard Group Inc. Lowers Holdings in Azenta, Inc. $AZTA - MarketBeat
Azenta, Inc. (AZTA) Presents at 47th Annual Raymond James Institutional Investor ConferenceSlideshow - Seeking Alpha
Royce & Associates LP Has $9.88 Million Position in Azenta, Inc. $AZTA - MarketBeat
How The Azenta (AZTA) Story Is Shifting With Analyst Rethinks And New Buyback Plan - Yahoo Finance
Azenta, Inc. (NASDAQ:AZTA) Short Interest Update - MarketBeat
Azenta stock hits 52-week low at 23.88 USD By Investing.com - Investing.com Canada
Azenta at 47th Annual Raymond James Conference: Strategic Turnaround Insights - Investing.com Australia
Azenta (NASDAQ:AZTA) Hits New 12-Month LowHere's What Happened - MarketBeat
AZTA SEC FilingsAzenta Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Azenta stock hits 52-week low at 23.88 USD - Investing.com South Africa
Azenta, Inc. (AZTA) Stock Analysis: Unveiling a 49.64% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Azenta, Inc. (NASDAQ:AZTA) Given Average Rating of "Hold" by Brokerages - MarketBeat
AZTA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Fulgent Genetics and Azenta Compared as Investments - National Today
Rate Hike: Can Azenta Inc keep up with sector leaders2025 Trading Volume Trends & Breakout Confirmation Alerts - baoquankhu1.vn
Azenta, Inc. (AZTA) Investor Outlook: Exploring a 37.95% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Finanzdaten der Azenta Inc-Aktie (AZTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):